UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM
For
the quarterly period ended
or
For the transition period from _____ to _____
Commission
File Number:
(Exact name of registrant as specified in its charter)
(State or other jurisdiction of incorporation or organization) |
(I.R.S. Employer Identification No.) |
(Address of principal executive offices) (Zip Code)
(Registrant’s telephone number, including area code)
N/A
(Former name, former address and former fiscal year, if changed since last report)
Securities registered pursuant to Section 12(b) of the Act:
| Title of each class | Trading Symbol(s) | Name of each exchange on which registered | ||
| The | ||||
| The |
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company, in Rule 12b-2 of the Exchange Act.
| Large accelerated filer ☐ | Accelerated filer ☐ |
| Smaller reporting company | |
| Emerging growth company |
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act).
Yes
☐ No
At May 20, 2024, the registrant had shares of common stock, par value $0.086 per share, outstanding.
TABLE OF CONTENTS
| 2 |
Reliance Global Group, Inc. and Subsidiaries
Condensed Consolidated Balance Sheets
(Unaudited)
| March 31, | December 31, | |||||||
| 2024 | 2023 | |||||||
| Assets | ||||||||
| Current assets: | ||||||||
| Cash | $ | $ | ||||||
| Restricted cash | ||||||||
| Accounts receivable | ||||||||
| Accounts receivable, related parties | ||||||||
| Other receivables | ||||||||
| Prepaid expense and other current assets | ||||||||
| Total current assets | ||||||||
| Property and equipment, net | ||||||||
| Right-of-use assets | ||||||||
| Intangibles, net | ||||||||
| Goodwill | ||||||||
| Other non-current assets | ||||||||
| Total assets | $ | $ | ||||||
| Current liabilities: | ||||||||
| Accounts payable and other accrued liabilities | $ | $ | ||||||
| Short term financing agreements | ||||||||
| Current portion of loans payables, related parties | ||||||||
| Other payables | ||||||||
| Current portion of long-term debt | ||||||||
| Current portion of leases payable | ||||||||
| Earn-out liability, current portion | ||||||||
| Total current liabilities | ||||||||
| Loans payable, related parties, less current portion | ||||||||
| Long term debt, less current portion | ||||||||
| Leases payable, less current portion | ||||||||
| Warrant liabilities | ||||||||
| Total liabilities | ||||||||
| Stockholders’ equity: | ||||||||
| Preferred stock, $ par value; shares authorized and and issued and outstanding as of March 31, 2024 and December 31, 2023, respectively | ||||||||
| Common stock, $ par value; shares authorized and and issued and outstanding as of March 31, 2024 and December 31, 2023, respectively | ||||||||
| Additional paid-in capital | ||||||||
| Accumulated deficit | ( | ) | ( | ) | ||||
| Total stockholders’ equity | ||||||||
| Total liabilities and stockholders’ equity | $ | $ | ||||||
The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.
| 3 |
Reliance Global Group, Inc. and Subsidiaries
Condensed Consolidated Statements of Operations
(Unaudited)
| Three Months ended | Three Months ended | |||||||
| March 31, 2024 | March 31, 2023 | |||||||
| Revenue | ||||||||
| Commission income | $ | $ | ||||||
| Total revenue | ||||||||
| Operating expenses | ||||||||
| Commission expense | ||||||||
| Salaries and wages | ||||||||
| General and administrative expenses | ||||||||
| Marketing and advertising | ||||||||
| Change in estimated acquisition earn-out payables | ||||||||
| Depreciation and amortization | ||||||||
| Asset impairments | ||||||||
| Total operating expenses | ||||||||
| Loss from operations | ( | ) | ( | ) | ||||
| Other (expense) income | ||||||||
| Interest expense | ( | ) | ( | ) | ||||
| Interest expense, related parties | ( | ) | ( | ) | ||||
| Other income, net | ||||||||
| Recognition and change in fair value of warrant liabilities | ||||||||
| Total other (expense) income | ( | ) | ||||||
| (Loss) income from continuing operations before tax | ( | ) | ||||||
| Income (loss) from discontinued operations before tax | ( | ) | ||||||
| Net loss | $ | ( | ) | $ | ( | ) | ||
| Basic (loss) earnings per share | ||||||||
| Continuing operations | $ | ( | ) | $ | ||||
| Discontinued operations | $ | $ | ( | ) | ||||
| Basic (loss) earnings per share | $ | ( | ) | $ | ( | ) | ||
| Diluted loss per share | ||||||||
| Continuing operations | $ | ( | ) | $ | ( | ) | ||
| Discontinued operations | $ | $ | ( | ) | ||||
| Diluted loss per share | $ | ( | ) | $ | ( | ) | ||
| Weighted average number of shares outstanding - basic | ||||||||
| Weighted average number of shares outstanding - diluted | ||||||||
The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.
| 4 |
Reliance Global Group, Inc. and Subsidiaries
Condensed Consolidated Statements of Stockholders’ Equity
(Unaudited)
| Three Months ended March 31, 2024 | ||||||||||||||||||||
| Common stock | Additional paid-in | Accumulated | ||||||||||||||||||
| Shares | Amount | capital | deficit | Total | ||||||||||||||||
| Balance, December 31, 2023 | $ | $ | $ | ( | ) | $ | ||||||||||||||
Common share payments for earn-outs | ||||||||||||||||||||
| Common shares issued for ATM share sales | ||||||||||||||||||||
| Common shares issued for Abeyance Share conversions | ( | ) | ||||||||||||||||||
| Common share based compensation | ||||||||||||||||||||
| Net loss | - | ( | ) | ( | ) | |||||||||||||||
| Balance, March 31, 2024 | $ | $ | $ | ( | ) | $ | ||||||||||||||
| Three Months ended March 31, 2023 | ||||||||||||||||||||
| Common stock | Additional paid-in | Accumulated | ||||||||||||||||||
| Shares | Amount | capital | deficit | Total | ||||||||||||||||
| Balance, December 31, 2022 | $ | $ | $ | ( | ) | $ | ||||||||||||||
| Common shares issued for earn-out liabilities | ||||||||||||||||||||
| Common shares issued to settle loan - Yes Americana | ||||||||||||||||||||
| Round up of Common shares due to reverse split | ( | ) | ( | ) | ||||||||||||||||
| Common shares issued in 2023 private placement | ||||||||||||||||||||
| Common share based compensation | - | |||||||||||||||||||
| Net loss | - | ( | ) | ( | ) | |||||||||||||||
| Balance, March 31, 2023 | $ | $ | $ | ( | ) | $ | ||||||||||||||
The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.
| 5 |
Reliance Global Group, Inc. and Subsidiaries and Predecessor
Condensed Consolidated Statements of Cash Flows
(Unaudited)
| For the 3 months ended March 31, | ||||||||
| 2024 | 2023 | |||||||
| CASH FLOWS FROM OPERATING ACTIVITIES: | ||||||||
| Net Income | $ | ( | ) | $ | ( | ) | ||
| Adjustment to reconcile net income to net cash used in operating activities: | ||||||||
| Depreciation and amortization | ||||||||
| Asset impairments | ||||||||
| Amortization of debt issuance costs and accretion of debt discount | ||||||||
| Non-cash lease expense (income) | ( | ) | ||||||
| Equity based compensation expense | ||||||||
| Recognition and change in fair value of warrant liability | ( | ) | ( | ) | ||||
| Earn-out fair value and write-off adjustments | ||||||||
| Change in operating assets and liabilities: | ||||||||
| Accounts receivable | ||||||||
| Accounts receivable, related parties | ||||||||
| Other receivables | ( | ) | ||||||
| Prepaid expense and other current assets | ||||||||
| Other non-current assets | ( | ) | ||||||
| Accounts payables and other accrued liabilities | ||||||||
| Other payables | ( | ) | ||||||
| Net cash used in continuing operating activities | ( | ) | ( | ) | ||||
| Net cash adjustments for discontinued operating activities | ||||||||
| Total net cash used in continuing and discontinued operating activities | ( | ) | ( | ) | ||||
| CASH FLOWS FROM INVESTING ACTIVITIES: | ||||||||
| Purchase of property and equipment | ( | ) | ( | ) | ||||
| Purchase of intangibles | ( | ) | ( | ) | ||||
| Net cash used in investing activities | ( | ) | ( | ) | ||||
| Net cash used in discontinued investing activities | ( | ) | ||||||
| Total net cash used in continuing and discontinued investing activities | ( | ) | ( | ) | ||||
| CASH FLOWS FROM FINANCING ACTIVITIES: | ||||||||
| Principal repayments of debt | ( | ) | ( | ) | ||||
| Proceeds of loans payable related parties | ||||||||
| Principal repayments of short term financings | ( | ) | ( | ) | ||||
| Payments of loans payable, related parties | ( | ) | ( | ) | ||||
| Proceeds from common shares issued through an at the market offering | ||||||||
| Cash payments on earn-out liability | ( | ) | ||||||
| Private Placement of shares and warrants | ||||||||
| Net cash used in and provided by continuing financing activities | ( | ) | ||||||
| Net cash used in discontinued financing activities | ( | ) | ||||||
| Total net cash (used in) and provided by continuing and discontinued financing activities | ( | ) | ||||||
| Net (decrease) and increase in cash and restricted cash | ( | ) | ||||||
| Cash and restricted cash at beginning of year | ||||||||
| Cash and restricted cash at end of year | $ | $ | ||||||
The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.
| 6 |
Reliance Global Group, Inc. and Subsidiaries
Notes to the Unaudited Condensed Consolidated Financial Statements
NOTE 1. SUMMARY OF BUSINESS AND SIGNIFICANT ACCOUNTING POLICIES
Reliance Global Group, Inc., formerly known as Ethos Media Network, Inc. (“RELI”, “Reliance”, or the “Company”), was incorporated in Florida on August 2, 2013.
Basis of Presentation and Principles of Consolidation
The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States of America (“U.S. GAAP”) for interim financial information and with the instructions for Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all the information and footnotes required by U.S. GAAP for complete financial statements. In the opinion of management, all adjustments (consisting of recurring accruals) necessary for a fair presentation have been included. These unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and the notes thereto, set forth in the Company’s Annual Report on Form 10-K for the year ended December 31, 2023 (the “Form 10-K”), as the same may be amended from time to time. Capitalized terms not defined in this Form 10-Q refer to capitalized terms as defined in the Form 10-K. Certain prior period accounts and balances in these condensed consolidated financial statements and notes thereto have been reclassified to conform to the current period’s presentation.
The accompanying unaudited condensed consolidated financial statements include the accounts of Reliance Global Group, Inc. and its wholly owned subsidiaries. All intercompany transactions and balances have been eliminated in consolidation.
Liquidity
As
of March 31, 2024, the Company’s reported cash and restricted cash aggregated balance was approximately $
Although there can be no assurance that debt or equity financing will be available on acceptable terms, the Company believes its financial position and its ability to raise capital to be reasonable and sufficient. Based on our assessment, we do not believe there are conditions or events that, in the aggregate, raise substantial doubt about the Company’s ability to continue as a going concern within one year of filing these financial statements with the Securities and Exchange Commission (“SEC”).
Use of Estimates
The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses, and related disclosures in the financial statements and accompanying notes. Management bases its estimates on historical experience and on assumptions believed to be reasonable under the circumstances. Actual results could differ materially from those estimates.
| 7 |
Cash and Restricted Cash
Cash and restricted cash reported on our condensed consolidated balance sheets are reconciled to the total shown on our condensed consolidated statements of cash flows as follows:
| March 31, 2024 | March 31, 2023 | |||||||
| Cash | $ | $ | ||||||
| Restricted cash | ||||||||
| Total cash and restricted cash | $ | $ | ||||||
Fair Value of Financial Instruments
Level 1 — Observable inputs reflecting quoted prices (unadjusted) in active markets for identical assets and liabilities;
Level 2 — Inputs other than quoted prices in active markets for identical assets and liabilities that are observable either directly or indirectly for substantially the full term of the asset or liability; and
Level 3 — Unobservable inputs for the asset or liability, which include management’s own assumption about the assumptions market participants would use in pricing the asset or liability, including assumptions about risk.
Warrant Liabilities: The Company re-measures the fair value of its Level 3 warrant liabilities at the balance sheet date, using a binomial option pricing model. The following summarizes the significant unobservable inputs:
| March 31, 2024 | December 31, 2023 | |||||||
| Stock price | $ | $ | ||||||
| Volatility | % | % | ||||||
| Time to expiry | ||||||||
| Dividend yield | % | % | ||||||
| Risk free rate | % | % | ||||||
The following reconciles fair value of the liability classified warrants:
| Series B warrant liabilities | Placement agent warrants | Total | ||||||||||
| Beginning balance, December 31, 2022 | $ | $ | $ | |||||||||
| Unrealized (gain) loss | ( | ) | ( | ) | ( | ) | ||||||
| Warrants exercised or exchanged | ( | ) | ( | ) | ||||||||
| Ending balance, December 31, 2023 | $ | $ | $ | |||||||||
| Unrealized (gain) loss | ( | ) | ( | ) | ||||||||
| Warrants exercised or exchanged | ||||||||||||
| Ending balance, March 31, 2024 | $ | $ | $ | |||||||||
| 8 |
Earn-out liabilities: The Company utilizes two valuation methods to value its Level 3 earn-out liabilities, a) the income valuation approach and b) the Monte Carlo simulation method. Key valuation and unobservable inputs for the income valuation approach include contingent payment arrangement terms, projected revenues and cash flows, rates of return, discount rates and probability assessments.
The following table reconciles fair value of earn-out liabilities for the periods ended March 31, 2024, and December 31, 2023:
| March 31, 2024 | December 31, 2023 | |||||||
| Beginning balance – January 1 | $ | $ | ||||||
| Acquisitions and settlements | ( | ) | ||||||
| Period adjustments: | ||||||||
| Fair value changes included in earnings* | ||||||||
| Earn-out payable in common shares | ( | ) | ( | ) | ||||
| Earn-out transferred to loans payable, related parties | ( | ) | ( | ) | ||||
| Ending balance | ||||||||
| Less: Current portion | ( | ) | ||||||
| Ending balance, less current portion | $ | $ | ||||||
| * |
Revenue Recognition
The following table disaggregates the Company’s revenue by line of business, showing commissions earned:
| Three Months ended March 31, 2024 | Medical | Life | Property and Casualty | Total | ||||||||||||
| EBS | $ | $ | $ | $ | ||||||||||||
| USBA | ||||||||||||||||
| CCS/UIS | ||||||||||||||||
| Montana | ||||||||||||||||
| Fortman | ||||||||||||||||
| Altruis | ||||||||||||||||
| Kush | ||||||||||||||||
| Reli Exchange | ||||||||||||||||
| Total | $ | $ | $ | $ | ||||||||||||
| 9 |
| Three Months ended March 31, 2023 | Medical | Life | Property and Casualty | Total | ||||||||||||
| EBS | $ | $ | $ | $ | ||||||||||||
| USBA | ||||||||||||||||
| CCS/UIS | ||||||||||||||||
| Montana | ||||||||||||||||
| Fortman | ||||||||||||||||
| Altruis | ||||||||||||||||
| Kush | ||||||||||||||||
| Reli Exchange | ||||||||||||||||
| Total | $ | $ | $ | $ | ||||||||||||
The following are customers representing 10% or more of total revenue:
| Three Months ended March 31, | ||||||||
| Insurance Carrier | 2024 | 2023 | ||||||
| Priority Health | % | % | ||||||
| BlueCross BlueShield | % | % | ||||||
No
other single customer accounted for more than
Income Taxes
The
Company recorded
As of March 31, 2024 and December 31, 2023, the Company provided a full valuation allowance against its net deferred tax assets since the Company believes it is more likely than not that its deferred tax assets will not be realized.
Recently Issued Accounting Pronouncements
We do not expect any recently issued accounting pronouncements to have a material effect on our financial statements.
| 10 |
NOTE 2. GOODWILL AND OTHER INTANGIBLE ASSETS
The following table rolls forward the Company’s goodwill balance for the periods ended March 31, 2024, and December 31, 2023, adjusted for discontinued operations.
| Goodwill | ||||
| December 31, 2022 | $ | |||
| Goodwill impairment recognized as of December 31, 2023 | ( | ) | ||
| December 31, 2023 | ||||
| March 31, 2024 | $ | |||
Asset Impairments:
During the quarter ended March 31, 2024, certain intangible assets stemming
from discontinued operations which were originally transferred to the Company’s operating entity, were determined to have carrying
values exceeding fair value, and thus were considered impaired. These intangible assets consisted of, customer relationships, and internally
developed and purchased software, with respective net of accumulated amortization asset values of, $
The following table sets forth the major categories of the Company’s intangible assets and the weighted-average remaining amortization period as of March 31, 2024:
| Weighted Average Remaining Amortization Period (Years) | Gross Carrying Amount | Accumulated Amortization | Net Carrying Amount | |||||||||||||
| Trade name and trademarks | $ | $ | ( | ) | $ | |||||||||||
| Internally developed software | ( | ) | ||||||||||||||
| Customer relationships | ( | ) | ||||||||||||||
| Purchased software | ( | ) | ||||||||||||||
| Video production assets | - | ( | ) | |||||||||||||
| Non-competition agreements | ( | ) | ||||||||||||||
| $ | $ | ( | ) | $ | ||||||||||||
| 11 |
The following table sets forth the major categories of the Company’s intangible assets and the weighted-average remaining amortization period as of December 31, 2023:
| Weighted Average Remaining Amortization period (Years) | Gross Carrying Amount | Accumulated Amortization | Net Carrying Amount | |||||||||||||
| Trade name and trademarks | $ | $ | ( | ) | $ | |||||||||||
| Internally developed software | ( | ) | ||||||||||||||
| Customer relationships | ( | ) | ||||||||||||||
| Purchased software | ( | ) | ||||||||||||||
| Video Production Assets | - | ( | ) | |||||||||||||
| Non-competition agreements | ( | ) | ||||||||||||||
| Trade name and trademarks | $ | $ | ( | ) | $ | |||||||||||
The following table reflects expected amortization expense as of March 31, 2024, for each of the following five years and thereafter:
| Years ending December 31, | Amortization Expense | |||
| 2024 (remainder of year) | $ | |||
| 2025 | ||||
| 2026 | ||||
| 2027 | ||||
| 2028 | ||||
| Thereafter | ||||
| Total | $ | |||
| 12 |
NOTE 3. LONG-TERM DEBT AND SHORT-TERM FINANCINGS
Long-Term Debt
The composition of the long-term debt follows:
March 31, 2024 | December 31, 2023 | |||||||
| Oak Street Funding LLC Term Loan for the acquisition of EBS and USBA, variable interest of Prime Rate plus | $ | $ | ||||||
| Oak Street Funding LLC Senior Secured Amortizing Credit Facility for the acquisition of CCS, variable interest of Prime Rate plus | ||||||||
| Oak Street Funding LLC Term Loan for the acquisition of SWMT, variable interest of Prime Rate plus | ||||||||
| Oak Street Funding LLC Term Loan for the acquisition of FIS, variable interest of Prime Rate plus | ||||||||
| Oak Street Funding LLC Term Loan for the acquisition of ABC, variable interest of Prime Rate plus | ||||||||
| Oak Street Funding LLC Term Loan for the acquisition of Barra, variable interest of Prime Rate plus | ||||||||
| Less: current portion | ( | ) | ( | ) | ||||
| Long-term debt | $ | $ | ||||||
Oak Street Funding LLC – Term Loans and Credit Facilities
| Fiscal year ending December 31, | Maturities of Long-Term Debt | |||
| 2024 (remainder of year) | $ | |||
| 2025 | ||||
| 2026 | ||||
| 2027 | ||||
| 2028 | ||||
| Thereafter | ||||
| Total | ||||
| Less: debt issuance costs | ( | ) | ||
| Total | $ | |||
| 13 |
Short-Term Financings
The
Company has various short-term notes payable for financed items such as insurance premiums and CRM software purchases. These are normally
paid in equal installments over a period of twelve months or less and carry interest rates up to
NOTE 4. WARRANT LIABILITIES
Series B Warrants
The Series B Warrant liability effective exercise price as of March 31,
2024 was $0.63, and the outstanding balance, inclusive of 16,303 PAW warrants as of March 31, 2024 and December 31, 2023 was $173,660
and $268,993 respectively, presented in the warrant liability account on the condensed consolidated balance sheets. Pursuant to the terms of the Series B Warrants, during the second quarter of 2024, the Series B Warrant exercise
price was reduced from $
For
the periods ended March 31, 2024, and 2023, net fair value gains recognized for the Series B Warrants inclusive of the PAW warrants were
$
NOTE 5. EQUITY
Common Stock
The Company is authorized to issue shares of common stock, $ par value. Each share of issued and outstanding common stock entitles the holder thereof to fully participate in all shareholder meetings, to cast one vote on each matter with respect to which shareholders have the right to vote, and to share ratably in all dividends and other distributions declared and paid with respect to common stock, as well as in the net assets of the corporation upon liquidation or dissolution.
During the first quarter of 2024, the Company issued shares through its ATM program, pursuant to Abeyance Share conversions and shares for equity-based compensation.
As of March 31, 2024 and December 31, 2023, there were and shares of common stock outstanding, respectively.
| 14 |
Abeyance Shares
During the quarter ended March 31, 2024 upon request from the institutional investor, the Company converted Abeyance Shares into Common Stock, thereby issuing shares which resulted in a remaining balance of of outstanding Abeyance Shares as of March 31, 2024.
During the second quarter of 2024, upon request from the institutional investor, the Company converted the remaining Abeyance Shares into Common Stock resulting in zero Abeyance Shares outstanding.
Series G Warrants
Pursuant to the terms of the Series G Warrants, during the second quarter of 2024, the Series G Warrant exercise
price was reduced from $
At Market Program (the “ATM”)
On
February 15, 2024, the Company entered into an At Market Issuance Sales Agreement (the “ATM Agreement”) with EF Hutton
LLC (the “Agent”), pursuant to which the Company may offer and sell, from time to time through the Agent, shares of its
Common Stock (the “Shares”), having an aggregate offering price of up to $
During
the first quarter of 2024 the Company sold shares of Common Stock under the ATM Agreement, at a price of $, receiving
proceeds, net of $
Subsequent
to the first quarter of 2024, the Company sold an additional
shares of Common Stock under the ATM Agreement, receiving proceeds, net of $
Equity-based Compensation
Total stock-based compensation expense recorded in general and administrative expenses in the condensed consolidated statements of operations for the three months ended March 31, 2024 and 2023 is $ and $, respectively.
| 15 |
Basic earnings per common share (“EPS”) applicable to common stockholders is computed by dividing earnings applicable to common stockholders by the weighted-average number of common shares outstanding.
If there is a loss from operations, diluted EPS is computed in the same manner as basic EPS is computed. Similarly, if the Company has net income but its preferred dividend adjustment made in computing income available to common stockholders results in a net loss available to common stockholders, diluted EPS would be computed in the same manner as basic EPS.
| Three Months | Three Months | |||||||
| Ended | Ended | |||||||
| March 31, 2024 | March 31, 2023 | |||||||
| (Loss) income from continuing operations | $ | ( | ) | $ | ||||
| Net (loss) income continuing operations, numerator, basic computation | ( | ) | ||||||
| Recognition and change in fair value of warrant liabilities | ( | ) | ||||||
| Net loss continuing operations, numerator, diluted computation | $ | ( | ) | $ | ( | ) | ||
| Weighted average common shares, basic | ||||||||
| Effect of series B warrants | ||||||||
| Weighted average common shares, dilutive | ||||||||
| Earnings (loss) per common share – basic | $ | ( | ) | $ | ||||
| Earnings (loss) per common share – diluted | $ | ( | ) | $ | ( | ) | ||
The reversal of the gain on the change fair value of the Series B warrant liability for the three months March 31, 2023 is included in the numerator of the dilutive EPS calculation to eliminate the effects the warrants as the impact is dilutive.
| For the Three Months Ended | ||||||||
March 31, 2024 | March 31, 2023 | |||||||
| Shares subject to outstanding common stock options | ||||||||
| Shares subject to outstanding Series A warrants | ||||||||
| Shares subject to outstanding Series B warrants and PAW’s | ||||||||
| Shares subject to outstanding Series F warrants | ||||||||
| Shares subject to outstanding Series G warrants | ||||||||
| Shares subject to PA Warrants | ||||||||
| Shares subject to unvested stock awards | ||||||||
NOTE 7. LEASES
Operating
lease expense for the three months ended March 31, 2024 and 2023 was $
| 16 |
Future minimum lease payments under these operating leases consists of the following:
| Period ending March 31, 2024 | Operating Lease Obligations | |||
| 2024 | $ | |||
| 2025 | ||||
| 2026 | ||||
| 2027 | ||||
| 2028 | ||||
| Thereafter | ||||
| Total undiscounted operating lease payments | ||||
| Less: Imputed interest | ||||
| Present value of operating lease liabilities | $ | |||
NOTE 8. COMMITMENTS AND CONTINGENCIES
Legal Contingencies
The
Company is subject to various legal proceedings and claims, either asserted or unasserted, arising in the ordinary course of business.
While the outcome of these claims cannot be predicted with certainty, management does not believe the outcome of any of these matters
will have a material adverse effect on our business, financial position, results of operations, or cash flows, and accordingly and
Earn-out liabilities
The following outlines changes to the Company’s earn-out liability balances for the respective periods ended March 31, 2024 and December 31, 2023:
| Fortman | Montana | Altruis | Kush | Barra | Total | |||||||||||||||||||
| Ending balance December 31, 2023 | $ | $ | $ | $ | $ | $ | ||||||||||||||||||
| Changes due to payments | ||||||||||||||||||||||||
| Changes due to fair value adjustments | ||||||||||||||||||||||||
| Payable in Common Stock | ( | ) | ( | ) | ||||||||||||||||||||
| Transfers to loans payable, related parties* | ( | ) | ( | ) | ||||||||||||||||||||
| Ending balance March 31, 2024 | $ | $ | $ | $ | $ | $ | ||||||||||||||||||
| Fortman | Montana | Altruis | Kush | Barra | Total | |||||||||||||||||||
| Ending balance December 31, 2022 | $ | $ | $ | $ | $ | $ | ||||||||||||||||||
| Payments | ( | ) | ( | ) | ( | ) | ( | ) | ( | ) | ||||||||||||||
| Estimate & fair value adjustments | ( | ) | ||||||||||||||||||||||
| Payable in Common Stock | ( | ) | ( | ) | ||||||||||||||||||||
| Reclass to loans payable, related parties* | ( | ) | ( | ) | ||||||||||||||||||||
| Ending balance December 31, 2023 | $ | $ | $ | $ | $ | $ | ||||||||||||||||||
| * |
| 17 |
NOTE 9. RELATED PARTY TRANSACTIONS
The
Company, Southwestern Montana Insurance Center, LLC, a Montana limited liability company (the “Subsidiary”), Southwestern
Montana Financial Center, Inc., a Montana corporation (the “Seller”), and Julie A. Blockey (the “Holder”, and
collectively with the Company, Subsidiary, and Seller, the “Parties”) entered into a purchase agreement on or around April
1, 2019 (the “Purchase Agreement”), whereby the Company purchased the business and certain assets noted within the Purchase
Agreement. On September 29, 2023, the Parties entered into a first amendment to the Purchase Agreement (the “First Amendment”).
Pursuant to the First Amendment, the Parties agreed to a total remaining balance of $
The following table summarizes the loans payable, related parties current and non-current accounts, and the interest expense related parties account as of and for the three-month period ended March 31, 2024 and December 31, 2023, as presented on the condensed consolidated balance sheets and condensed consolidated statements of operations, respectively:
Current portion of loans payables, related parties | Loans payable, related parties, less current portion | Interest expense, related parties | ||||||||||||||||||||||
| Related Party | March 31, 2024 | December 31, 2023 | March 31, 2024 | December 31, 2023 | March 31, 2024 | March 31, 2023 | ||||||||||||||||||
| Loan to Employee | $ | $ | $ | $ | $ | $ | ||||||||||||||||||
| Barra | $ | |||||||||||||||||||||||
| Fortman | ||||||||||||||||||||||||
| Montana | ||||||||||||||||||||||||
| Total | $ | $ | $ | $ | $ | $ | ||||||||||||||||||
NOTE 10. SUBSEQUENT EVENTS
On May 14, 2024, the Company entered into a Stock
Exchange Agreement to acquire Spetner Associates (“Spetner”), dated as of
| 18 |
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations
Overview
Reliance Global Group, Inc. (the “Company”) operates as a diversified company engaging in business in the insurance market, as well as other related sectors. Our focus is to grow the Company by pursuing an aggressive acquisition strategy, initially and primarily focused upon wholesale and retail insurance agencies.
In the insurance sector, our management has extensive experience acquiring and managing insurance portfolios in several states, as well as developing specialized programs targeting niche markets. Our primary strategy is to identify specific risk to reward arbitrage opportunities and develop these on a national platform, thereby increasing revenues and returns, and then identify and acquire undervalued wholesale and retail insurance agencies with operations in growing or underserved segments, expand and optimize their operations, and achieve asset value appreciation while generating interim cash flows.
As part of our growth and acquisition strategy, we continue to survey the current insurance market for value-add acquisition opportunities. As of March 31, 2024, we have acquired nine insurance agencies.
Over the next 12 months, we plan to focus on the expansion and growth of our business through continued asset acquisitions in insurance markets and organic growth of our current insurance operations through geographic expansion and market share growth, and more specifically, on May 14, 2024, the Company announced the signing of a definitive agreement to acquire Spetner Associates (“Spetner”), a well-established benefits enrollment company that, through its BenManage benefits enrollment company, is a leading provider of voluntary benefits to over 75,000 employees throughout the United States. Pursuant to a Stock Exchange Agreement (the “SE Agreement”), dated as of May 14, 2024, by and among the parties thereto, the Company shall: (i) acquire eighty percent (80%) of the issued and outstanding shares of common stock, par value $1.00 per share, of Spetner (the “Spetner Common Stock”) for the amount of $13,714,286 (which shall be paid in $8 million cash, the issuance of certain shares of common stock of the Company, and the issuance a promissory note of the Company); and (ii) have the sole option to acquire the remaining twenty percent (20%) of the Spetner Common Stock for a predetermined amount based on a multiple of EBITDA.
Further, we launched our 5MinuteInsure.com (“5MI”) Insurtech platform during 2021 which expanded our national footprint. 5MI is a high-tech proprietary tool developed by us as a business to consumer portal which enables consumers to instantly compare quotes from multiple carriers and purchase their car and home insurance in a time efficient and effective manner. 5MI taps into the growing number of online shoppers and utilizes advanced artificial intelligence and data mining techniques, to provide competitive insurance quotes in around 5 minutes with minimal data input needed from the consumer. The platform launched during the summer of 2021 and currently operates in 46 states offering coverage with up to 30 highly rated insurance carriers.
With the acquisition of Barra, we launched RELI Exchange, our business-to-business (“B2B”) InsurTech platform and agency partner network that builds on the artificial intelligence and data mining backbone of 5MinuteInsure.com. Through RELI Exchange we on-board agency partners and provide them with an InsurTech platform white labeled, designed and branded specifically for their business. This combines the best of digital and human capabilities by providing our agency partners and their customers quotes from multiple carriers within minutes. Since its inception, RELI Exchange has increased its agent roster by more than 130%.
Business Operations
We’ve adopted a ‘One-Firm’ strategy, whereby the Reliance owned and operated agencies come together to operate as one cohesive unit which allows for efficient and effective cross-selling, cross-collaboration, and the effective deployment of the Company’s human capital. This strategy also aims to enhance the Company’s overall market presence across the U.S., with all business lines operating under the RELI Exchange brand. It’s expected to benefit agents and clients by improving relationships with carriers, leading to better commission and bonus contracts due to higher business volumes. The approach also strengthens the capability of RELI Exchange agency partners in securing diverse insurance policies and fosters increased cross-selling opportunities. This unified strategy positions the company for rapid scaling and integration of accretive acquisitions, expanding its industry reach.
Business Trends and Uncertainties
The insurance intermediary business is highly competitive, and we actively compete with numerous firms for customers and insurance companies, many of which have relationships with insurance companies, or have a significant presence in niche insurance markets that may give them an advantage over us. Other competitive concerns may include the quality of our products and services, our pricing and the ability of some of our customers to self-insure and the entrance of technology companies into the insurance intermediary business. Several insurance companies are engaged in the direct sale of insurance, primarily to individuals, and do not pay commissions to agents and brokers.
Financial Instruments
The Company’s financial instruments as of March 31, 2024, consist of derivative warrants. These are accounted at fair value as of inception/issuance date, and at fair value as of each subsequent balance sheet date. Any change in fair value is recorded as non-operating, (non-cash) gain or loss.
| 19 |
Insurance Operations
Our insurance operations focus on the acquisition and management of insurance agencies throughout the U.S. Our primary focus is to pinpoint undervalued wholesale and retail insurance agencies with operations in growing or underserved segments (including healthcare and Medicare, as well as personal and commercial insurance lines). We then focus on expanding their operations on a national platform and improving operational efficiencies to achieve asset value appreciation while generating interim cash flows. In the insurance sector, our management team has over 100 years of experience acquiring and managing insurance portfolios in several states, as well as developing specialized programs targeting niche markets. We plan to accomplish these objectives by acquiring wholesale and retail insurance agencies it deems to represent a good buying opportunity (as opposed to insurance carriers) as insurance agencies bear no insurance risk. Once acquired, we plan to develop them on a national platform to increase revenues and profits through a synergetic structure. The Company is initially focused on segments that are underserved or growing, including healthcare and Medicare, as well as personal and commercial insurance lines.
Insurance Acquisitions and Strategic Activities
As of the balance sheet date, we have acquired multiple insurance brokerages (see table below). As our acquisition strategy continues, our reach within the insurance arena can provide us with the ability to offer lower rates, which could boost our competitive position within the industry. In furtherance of this strategy, on May 14, 2024, the Company entered into a Stock Exchange Agreement to acquire Spetner Associates (“Spetner”) for cash, stock and issuance of a promissory note. Spetner is a well-established benefits enrollment company that, through its BenManage benefits enrollment company, is a leading provider of voluntary benefits to over 75,000 employees throughout the United States. Completion of the transaction is subject to standard and stipulated closing. See “Note 10. Subsequent Events” to the financial statements included elsewhere in this Quarterly Report on Form 10-Q.
| Acquired | Reliance 100% Controlled Entity |
Date | Location | Line of Business | ||||
| U.S. Benefits Alliance, LLC (USBA) | US Benefits Alliance, LLC | October 24, 2018 | Michigan | Health Insurance | ||||
| Employee Benefit Solutions, LLC (EBS) | Employee Benefits Solutions, LLC | October 24, 2018 | Michigan | Health Insurance | ||||
| Commercial Solutions of Insurance Agency, LLC (CCS or Commercial Solutions) | Commercial Coverage Solutions LLC | December 1, 2018 | New Jersey | P&C – Trucking Industry | ||||
| Southwestern Montana Insurance Center, Inc. (Southwestern Montana or Montana) | Southwestern Montana Insurance Center, LLC | April 1, 2019 | Montana | Group Health Insurance | ||||
| Fortman Insurance Agency, LLC (Fortman or Fortman Insurance) | Fortman Insurance Solutions, LLC | May 1, 2019 | Ohio | P&C and Health Insurance | ||||
| Altruis Benefits Consultants, Inc. (Altruis) | Altruis Benefits Corporation | September 1, 2019 | Michigan | Health Insurance | ||||
| UIS Agency, LLC (UIS) | UIS Agency, LLC | August 17, 2020 | New York | P&C – Trucking Industry | ||||
| J.P. Kush and Associates, Inc. (Kush) | Kush Benefit Solutions, LLC | May 1, 2021 | Michigan | Health Insurance | ||||
| Barra & Associates, LLC | RELI Exchange, LLC | April 26, 2022 | Illinois | Health Insurance |
| 20 |
Recent Developments
Non-GAAP Measure
The Company believes certain financial measures which meet the definition of non-GAAP financial measures, as defined in Regulation G of the SEC rules, provide important supplemental information. Namely our key financial performance metric Adjusted EBITDA (“AEBITDA”) is a non-GAAP financial measure that is not in accordance with, or an alternative to, measures prepared in accordance with GAAP. “AEBITDA” is defined as earnings before interest, taxes, depreciation, and amortization (EBITDA) with additional adjustments as further outlined below, to result in Adjusted EBITDA (or “AEBITDA”). The Company considers AEBITDA an important financial metric because it provides a meaningful financial measure of the quality of the Company’s operational, cash impacted and recurring earnings and operating performance across reporting periods. Other companies may calculate Adjusted EBITDA differently than we do, which might limit its usefulness as a comparative measure to other companies in the industry. AEBITDA is used by management in addition to and in conjunction (and not as a substitute) with the results presented in accordance with GAAP. Management uses AEBITDA to evaluate the Company’s operational performance, including earnings across reporting periods and the merits for implementing cost-cutting measures. We have presented AEBITDA solely as supplemental disclosure because we believe it allows for a more complete analysis of results of operations and assists investors and analysts in comparing our operating performance across reporting periods on a consistent basis by excluding items that we do not believe are indicative of our core operating performance. Consistent with Regulation G, a description of such information is provided below herein and tabular reconciliations of this supplemental non-GAAP financial information to our most comparable GAAP information are contained in this Report on Form 10-Q under “Results of Operations”.
We exclude the following items, and the following items define our non-GAAP financial measure AEBITDA:
| ● | Interest and related party interest expense: Unrelated to core Company operations and excluded to provide more meaningful supplemental information regarding the Company’s core operational performance. | |
| ● | Depreciation and amortization: Non-cash charge, excluded to provide more meaningful supplemental information regarding the Company’s core operational performance. | |
| ● | Goodwill and/or asset impairments: Non-cash charge, excluded to provide more meaningful supplemental information regarding the Company’s core operational performance. | |
| ● | Equity-based compensation: Non-cash compensation provided to employees and service providers, excluded to provide more meaningful supplemental information regarding the Company’s core cash impacted operational performance. | |
| ● | Change in estimated acquisition earn-out payables: An Earn-out liability is a liability to the seller upon an acquisition which is contingent on future earnings. These liabilities are valued at each reporting period and the changes are reported as either a gain or loss in the change in estimated acquisition earn-out payables account in the consolidated statements of operations. The gain or loss is non-cash, can be highly volatile and overall is not deemed relevant to ongoing operations, thus, it’s excluded to provide more meaningful supplemental information regarding the Company’s core operational performance. | |
| ● | Recognition and change in fair value of warrant liabilities: This account includes changes to derivative warrant liabilities which are valued at each reporting period and could result in either a gain or loss. The period changes do not impact cash, can be highly volatile, and are unrelated to ongoing operations, and thus are excluded to provide more meaningful supplemental information regarding the Company’s core operational performance. | |
| ● | Other income (expense), net: Includes non-routine income or expenses and other individually de minimis items and is thus excluded as unrelated to core operations of the company. | |
| ● | Transactional costs: This includes expenses related to mergers, acquisitions, financings and refinancings, and amendments or modification to indebtedness. Thes costs are unrelated to primary Company operations and are excluded to provide more meaningful supplemental information regarding the Company’s core operational performance. | |
| ● | Non recuring costs: This account includes non-recurring non-operational items, related to costs incurred for a legal suit the Company has filed against one of the third parties involved in the discontinued operations and is excluded to provide more meaningful supplemental information regarding the Company’s core operational performance. | |
| ● | Loss from discontinued operations before tax: This account includes the net results from discontinued operations, and since discontinued, are unrelated to the Company’s ongoing operations and thus excluded to provide more meaningful supplemental information regarding the Company’s core operational performance. |
Refer to the reconciliation of net (loss) income to AEBITDA, illustrated below in tabular format.
| 21 |
Results of Operations
RELIANCE GLOBAL GROUP, INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF OPERATIONS ANALYTICS
Comparison of the three months ended March 31, 2024 to the three months ended March 31, 2023
| March 31, 2024 | March 31, 2023 | Value Fluctuation | Percent Fluctuation | Explanations | ||||||||||||||
| Commission Income | $ | 4,082,438 | $ | 3,939,103 | $ | 143,335 | 4 | % | Increased commission income primarily driven by sustained organic growth. | |||||||||
| Commission Expense | 1,276,542 | 1,083,326 | 193,216 | 18 | % | Commission expense increase primarily correlates to the growth and activity in commission income. | ||||||||||||
| Salaries and wages | 1,831,662 | 1,755,894 | 75,768 | 4 | % | Increase in salaries and wages relates to standard annual inflation adjusted pay. | ||||||||||||
| General and administrative expenses (“G&A”) | 1,374,890 | 837,766 | 537,124 | 64 | % | Increased G&A is driven by higher acquisition related and regulatory compliance costs. | ||||||||||||
| Marketing and advertising (“M&A”) | 127,042 | 136,571 | (9,529 | ) | -7 | % | M&A costs substantially similar to prior year. | |||||||||||
| Change in estimated acquisition earn-out payables | 47,761 | 476,692 | (428,931 | ) | -90 | % | Estimated acquisition earn-out payables decrease due to adjustments of estimated terminal payments and fair value thereof. | |||||||||||
| Depreciation and amortization | 534,152 | 653,778 | (119,626 | ) | -18 | % | Depreciation and amortization decrease is due to asset impairments in the current period. | |||||||||||
| Asset impairment | 3,922,110 | - | 3,922,110 | Increase in asset impairments is due to impairment of certain intangible assets. | ||||||||||||||
| Total operating expenses | 9,114,159 | 4,944,027 | 4,170,132 | 84 | % | |||||||||||||
| - | ||||||||||||||||||
| Loss from operations | (5,031,721 | ) | (1,004,924 | ) | (4,026,797 | ) | 401 | % | ||||||||||
| - | ||||||||||||||||||
| Other (expense) income | - | |||||||||||||||||
| Interest expense | (369,677 | ) | (351,823 | ) | (17,854 | ) | 5 | % | Interest expense increase primarily due to overall increased interest rate environment and new acquisition related debt financing. | |||||||||
| Interest expense, related parties | (40,609 | ) | (41,477 | ) | 868 | -2 | % | Decreased related party interest primarily due to high interest accruing loan balances paid down. | ||||||||||
| Other income, net | 11 | 3,949 | (3,938 | ) | -100 | % | Other income (expense) decrease primarily due to certain non-recurring and non-significant other income sources. | |||||||||||
| Recognition and change in fair value of warrant liabilities | 95,333 | 4,266,231 | (4,170,898 | ) | -98 | % | Decrease in gain due to fair value changes in derivative warrant liabilities carried at fair value. | |||||||||||
| Total other (expense) income | (314,942 | ) | 3,876,880 | (4,191,822 | ) | -108 | % | |||||||||||
| Income (loss) from continuing operations before tax | (5,346,663 | ) | 2,871,956 | (8,218,619 | ) | -286 | % | |||||||||||
| Income (loss) from discontinued operations before tax | - | (4,660,494 | ) | 4,660,494 | -100 | % | Decreased loss primarily stems from the complete winding down of discontinued operations. | |||||||||||
| Net loss | $ | (5,346,663 | ) | $ | (1,788,538 | ) | (3,558,125 | ) | 199 | % | ||||||||
| Non-GAAP Measure | ||||||||||||||||||
| AEBITDA | (73,654 | ) | 169,343 | (242,997 | ) | -143 | % | AEBITDA swing influenced by factors outlined above. | ||||||||||
| 22 |
Non-GAAP Reconciliation from Net (Loss) Income to AEBITDA
The following table provides a reconciliation from net (loss) income to AEBITDA (adjusted EBITDA) for the years ended December 31, 2023 and December 31, 2022.
| The Quarter ended | The Quarter ended | |||||||
| March 31, 2024 | March 31, 2023 | |||||||
| Net loss | $ | (5,346,663 | ) | $ | (1,788,538 | ) | ||
| Adjustments: | ||||||||
| Interest and related party interest expense | 410,286 | 393,300 | ||||||
| Depreciation and amortization | 534,152 | 653,778 | ||||||
| Asset impairment | 3,922,110 | - | ||||||
| Equity-based compensation employees, directors, and service providers | 154,912 | 43,797 | ||||||
| Change in estimated acquisition earn-out payables | 47,761 | 476,692 | ||||||
| Other income, net | (11 | ) | (3,949 | ) | ||||
| Recognition and change in fair value of warrant liabilities | (95,333 | ) | (4,266,231 | ) | ||||
| Transactional costs | 253,893 | - | ||||||
| Nonrecurring costs | 45,239 | - | ||||||
| Loss from discontinued operations before tax | - | 4,660,494 | ||||||
| Total adjustments | 5,273,009 | 1,957,881 | ||||||
| AEBITDA | $ | (73,654 | ) | $ | 169,343 | |||
Liquidity and capital resources
As of March 31, 2024, we had a cash balance of approximately $2,113,000 and working capital deficiency of approximately $120,000, compared with a cash balance of approximately $2,739,000 and working capital of approximately $1,189,000 at December 31, 2023. During the first quarter of 2024 the Company entered into an At Market Issuance Sales Agreement with EF Hutton as sales agent (the “ATM Agreement”) under which the Company may offer and sell, from time to time through the sales agent, shares of its Common Stock (the “Shares”), having an aggregate offering price of up to $858,637. Under the ATM Agreement, the Company pays the sales agent a commission equal to 3.5% of the aggregate gross proceeds of any sales of common stock under the ATM Agreement.
During the quarter ended March 31, 2024, the Company sold 187,614 shares of Common Stock under the ATM Agreement, at a price of $0.6891, receiving proceeds, net of $4,636 in sales agent commissions and fees, of $124,649. As of March 31, 2024, the net remaining amount we are permitted to sell under the ATM Agreement was $729,352.
During the period from April 1, 2024 through May 20, 2024, the Company sold 1,320,829 shares of Common Stock under the ATM Agreement, receiving proceeds, net of $15,905 agent commissions and fees of $385,052. As of May 20, the net remaining amount we are permitted to sell under the ATM Agreement was $328,395.
Pursuant to the terms of the Series B Warrants and Series G Warrants, during the second quarter of 2024, the Series B Warrants and Series G Warrants respective exercise prices reduced from $0.63 and $0.6562 per share to $0.26 and $0.26 per share as a result of dilutive issuances of our Common Stock.
Inflation
The Company generally may be impacted by rising costs for certain inflation-sensitive operating expenses such as labor, employee benefits, and facility leases. The Company believes inflation could have a material impact to pricing and operating expenses in future periods due to the state of the economy and current inflation rates.
Off-balance sheet arrangements
We do not have any off-balance sheet arrangements as such term is defined in Regulation S-K.
Cash Flows
Three Months Ended March 31, | ||||||||
| 2024 | 2023 | |||||||
| Net cash used in operating activities | $ | (204,382 | ) | (1,064,878 | ) | |||
| Net cash used in investing activities | (29,444 | ) | (96,297 | ) | ||||
| Net cash (used in) provided by financing activities | (392,100 | ) | 2,805,700 | |||||
| Net (decrease) increase in cash, cash equivalents, and restricted cash | $ | (625,926 | ) | $ | 1,644,525 | |||
| 23 |
Operating Activities
Net cash used in operating activities for the three months ended March 31, 2024 was approximately $204,000, compared to net cash flows used in operating activities of approximately $1.1 million for the three months ended March 31, 2023. The cash used includes net loss of approximately $5,347,000, decreased by approximate non-cash adjustments of $5,142,000 related to asset impairments of approximately $3,922,000, income of recognition and change in fair value of warrant liabilities of approximately $95,000, depreciation and amortization of approximately $534,000, other small adjustments totaling approximately $79,000, as well as a net increase in cash due to changes of net working capital items of approximately $702,000.
Investing Activities
During the three months ended March 31, 2024, cash flows used in investing activities approximated $29,000 compared to cash flows used in investing activities of approximately $96,000 for the three months ended March 31, 2023. The cash used is primarily related to the purchase of property and equipment.
Financing Activities
During the three months ended March 31, 2024, approximate cash used in financing activities was $392,000 as compared to approximately $2.8 million provided for the three months ended March 31, 2023. Net cash used in financing activities relates to proceeds from common shares issued pursuant to the ATM Agreement totaling approximately $125,000, offset by net debt principal, short term financings, and related party payables repayments of approximately $517,000.
Significant Accounting Policies and Estimates
We describe our significant accounting policies in Note 2, Summary of Significant Accounting Policies, of the Notes to Consolidated Financial Statements, and our critical accounting estimates in Item 7, Management’s Discussion and Analysis of Financial Condition and Results of Operations, in our Annual Report on Form 10-K for the fiscal year ended December 31, 2023. There have been no significant changes in our significant accounting policies or critical accounting estimates since the end of fiscal year 2023.
Item 3. Quantitative and Qualitative Disclosures About Market Risk.
Not applicable.
Item 4. Controls and Procedures
Evaluation of Disclosure Controls and Procedures
The term “disclosure controls and procedures,” as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), refers to controls and procedures that are designed to ensure that information required to be disclosed by a company in the reports that it files or submits under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the SEC’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that such information is accumulated and communicated to a company’s management, including its principal executive and principal financial officers, as appropriate to allow timely decisions regarding required disclosure. Management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving their objectives and management necessarily applies its judgment in evaluating the cost-benefit relationship of possible controls and procedures.
| 24 |
Our Chief Executive Officer and Chief Financial Officer have evaluated the effectiveness of our disclosure controls and procedures as of March 31, 2024, and determined them to be effective.
Changes in Internal Control over Financial Reporting
During fiscal year 2024, the Company revised its internal controls over its goodwill evaluation process to ensure that any testing performed at interim dates, are rolled forward to the financial statements reporting date. Aside for the foregoing, there have been no other changes in our internal control over financial reporting, as such term is defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act, during our most recently completed fiscal quarter which is the subject of this report that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.
PART II
Item 1. Legal Proceedings.
We are subject to various legal proceedings and claims, either asserted or unasserted, arising in the ordinary course of business. While the outcome of these claims cannot be predicted with certainty, management does not believe the outcome of any of these matters will have a material adverse effect on our business, financial position, results of operations, or cash flows, and accordingly, no legal contingencies are accrued as of March 31, 2024. Litigation relating to the insurance brokerage industry is not uncommon. As such we, from time to time have been, subject to such litigation. No assurances can be given with respect to the extent or outcome of any such litigation in the future.
Item 1A. Risk Factors.
Investing in our common stock involves a high degree of risk. You should consider carefully the information disclosed in Part I, Item 1A, “Risk Factors,” contained in our Annual Report on Form 10-K for the year ended December 31, 2023. Except as disclosed below, there have been no material changes from the risk factors disclosed in our Annual Report on Form 10-K for the year ended December 31, 2023, as amended from time to time.
The exercise of all or any number of outstanding Series G Warrants may dilute a shareholders holding of shares of our common stock.
We have issued 4,210,528 Series G Warrants providing for the right to purchase 4,4210,528 shares of our common stock at an initial exercise price of $0.6562 per share which price was reduced to $0.26 per share effective as of May 10, 2024 pursuant to a price reset provision pursuant to the terms of the Series G Warrants and the Company’s issuance of shares of its Common Stock pursuant to the ATM. Our shareholders could be subject to increased dilution upon the exercise of the Series G Warrants. In addition, the exercise of the Series G Warrants and the subsequent sale of shares of common stock issued thereby, could have an adverse effect on the market for our common stock, including the price that a shareholder could obtain for their shares. Further, our shareholders may experience dilution in the value of their investment in our common stock upon the exercise of the Series G Warrants.
The number of shares of common stock which may be issued upon exercise of our Series G Warrants is significant in relation to our currently outstanding common stock and could cause downward pressure on the market price for our common stock.
The number of shares of common stock issuable upon exercise of our outstanding Series G Warrants is significant in relation to the number of shares of common stock currently outstanding. If the holder of the Series G Warrants determines to sell a substantial number of shares into the market at any given time, there may not be sufficient demand in the market to purchase the shares without a decline in the market price for our common stock. Moreover, continuous sales into the market of a number of shares in excess of the typical trading volume for our common stock, or even the availability of such a large number of shares, could depress the trading market for our common stock over an extended period of time.
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.
None that have not been previously disclosed in our filings with the SEC.
Item 3. Defaults Upon Senior Securities.
Not applicable.
Item 4. Mine Safety Disclosures.
Not applicable.
Item 5. Other Information.
Not applicable.
| 25 |
Item 6. Exhibits
The following exhibits are filed with this Form 10-Q.
*Filed herewith
**Furnished herewith
| 26 |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
| Reliance Global Group, Inc. | ||
| Date: May 20, 2024 | By: | /s/ Ezra Beyman |
| Ezra Beyman | ||
| Chief Executive Officer | ||
| (principal executive officer) | ||
| Date: May 20, 2024 | By: | /s/ Joel Markovits |
| Joel Markovits | ||
| Chief Financial Officer | ||
| (principal financial officer and principal accounting officer) | ||
| 27 |